JP2019504895A5 - - Google Patents

Download PDF

Info

Publication number
JP2019504895A5
JP2019504895A5 JP2018560744A JP2018560744A JP2019504895A5 JP 2019504895 A5 JP2019504895 A5 JP 2019504895A5 JP 2018560744 A JP2018560744 A JP 2018560744A JP 2018560744 A JP2018560744 A JP 2018560744A JP 2019504895 A5 JP2019504895 A5 JP 2019504895A5
Authority
JP
Japan
Prior art keywords
biodegradable particles
composition according
composition
encapsulated
cedar pollen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018560744A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019504895A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/017248 external-priority patent/WO2017139498A1/en
Publication of JP2019504895A publication Critical patent/JP2019504895A/ja
Publication of JP2019504895A5 publication Critical patent/JP2019504895A5/ja
Priority to JP2022059997A priority Critical patent/JP2022101576A/ja
Priority to JP2025001876A priority patent/JP2025069142A/ja
Pending legal-status Critical Current

Links

JP2018560744A 2016-02-09 2017-02-09 スギ花粉エピトープを封入するtimp(組織性メタロプロテアーゼ阻害因子) Pending JP2019504895A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022059997A JP2022101576A (ja) 2016-02-09 2022-03-31 スギ花粉エピトープを封入するtimp(組織性メタロプロテアーゼ阻害因子)
JP2025001876A JP2025069142A (ja) 2016-02-09 2025-01-06 スギ花粉エピトープを封入するtimp(組織性メタロプロテアーゼ阻害因子)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662293261P 2016-02-09 2016-02-09
US62/293,261 2016-02-09
PCT/US2017/017248 WO2017139498A1 (en) 2016-02-09 2017-02-09 Timps encapsulating japanese cedar pollen epitopes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022059997A Division JP2022101576A (ja) 2016-02-09 2022-03-31 スギ花粉エピトープを封入するtimp(組織性メタロプロテアーゼ阻害因子)

Publications (2)

Publication Number Publication Date
JP2019504895A JP2019504895A (ja) 2019-02-21
JP2019504895A5 true JP2019504895A5 (enExample) 2020-03-19

Family

ID=59563413

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018560744A Pending JP2019504895A (ja) 2016-02-09 2017-02-09 スギ花粉エピトープを封入するtimp(組織性メタロプロテアーゼ阻害因子)
JP2022059997A Pending JP2022101576A (ja) 2016-02-09 2022-03-31 スギ花粉エピトープを封入するtimp(組織性メタロプロテアーゼ阻害因子)
JP2025001876A Pending JP2025069142A (ja) 2016-02-09 2025-01-06 スギ花粉エピトープを封入するtimp(組織性メタロプロテアーゼ阻害因子)

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022059997A Pending JP2022101576A (ja) 2016-02-09 2022-03-31 スギ花粉エピトープを封入するtimp(組織性メタロプロテアーゼ阻害因子)
JP2025001876A Pending JP2025069142A (ja) 2016-02-09 2025-01-06 スギ花粉エピトープを封入するtimp(組織性メタロプロテアーゼ阻害因子)

Country Status (3)

Country Link
JP (3) JP2019504895A (enExample)
KR (1) KR20180105243A (enExample)
WO (1) WO2017139498A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011289579B2 (en) 2010-08-10 2016-11-17 Ecole Polytechnique Federale De Lausanne Erythrocyte-binding therapeutics
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
CA2907915C (en) 2013-04-03 2023-03-07 Allertein Therapeutics, Llc Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
CA2946064C (en) 2014-02-21 2023-09-26 Ecole Polytechnique Federale De Lausanne (Epfl) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US20190365656A1 (en) * 2016-01-04 2019-12-05 Cour Pharmaceuticals Development Company, Inc. Particles encapsulating fusion proteins containing linked epitopes
EP3638296A1 (en) 2017-06-16 2020-04-22 The University Of Chicago Compositions and methods for inducing immune tolerance
EP3790577A4 (en) 2018-05-09 2022-04-27 The University of Chicago COMPOSITIONS AND METHODS RELATED TO IMMUNTOLERANCE
US12528848B2 (en) 2018-05-25 2026-01-20 The Wistar Institute Of Anatomy And Biology Tumor-specific neoantigens and methods of using the same
JP6982039B2 (ja) * 2019-09-24 2021-12-17 鳥居薬品株式会社 ヒノキ花粉抗原に対するモノクローナル抗体及びその用途
IL307722A (en) * 2021-04-16 2023-12-01 Cour Pharmaceuticals Dev Company Inc A method of monitoring the existence of immunological tolerance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007024026A1 (ja) * 2005-08-25 2007-03-01 Taiho Pharmaceutical Co., Ltd. T細胞認識エピトープペプチドを固定化又は内包化した生分解性ナノ粒子
JP2014524902A (ja) * 2011-06-14 2014-09-25 アメリカ合衆国 Tem8抗体、そのコンジュゲートおよびそれらの使用
DK3033102T4 (da) * 2013-08-13 2024-02-26 Univ Northwestern Peptidkonjugerede partikler

Similar Documents

Publication Publication Date Title
RU2016107998A (ru) Частицы, конъюгированные с пептидом
Acar et al. Self-assembling peptide-based building blocks in medical applications
Grego et al. Polymeric nanoparticle-based vaccine adjuvants and delivery vehicles
JP2016511747A5 (enExample)
Lee et al. Biodegradable viral nanoparticle/polymer implants prepared via melt-processing
Pavot et al. Poly (lactic acid) and poly (lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery
Petersen et al. Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen
Malik et al. Trimethyl chitosan nanoparticles encapsulated protective antigen protects the mice against anthrax
Gutjahr et al. Biodegradable polymeric nanoparticles-based vaccine adjuvants for lymph nodes targeting
Joshi et al. Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses
RU2014124682A (ru) Полимерные белковые микрочастицы
Rauta et al. Parenteral immunization of PLA/PLGA nanoparticle encapsulating outer membrane protein (Omp) from Aeromonas hydrophila: Evaluation of immunostimulatory action in Labeo rohita (rohu)
JP2019507113A5 (enExample)
JP2014533698A5 (enExample)
JP2018503668A5 (enExample)
JP2017538672A5 (enExample)
Mishra et al. Biodegradable polymer based particulate carrier (s) for the delivery of proteins and peptides
KR20160003212A (ko) 면역 관용의 유도를 위한 특정된 약역학적 유효 수명을 갖는 면역억제제 및 항원의 전달
CN114306638A (zh) 从合成纳米载体中控制释放免疫抑制剂
JP2011525477A5 (enExample)
Craparo et al. Application of polymeric nanoparticles in immunotherapy
JP2021502807A5 (enExample)
JP2009520758A5 (enExample)
JP2018503736A5 (enExample)
Batty et al. Vinyl sulfone-functionalized acetalated dextran microparticles as a subunit broadly acting influenza vaccine